Solventum Holds Steady with Stable 2026 EPS Estimate and Cost-Saving Program

Earnings
โดย Zacks Investment Research·Read original
Summary · why it matters

Solventum Corporation is positioned for growth driven by strong demand and innovation, though raw material cost concerns linger. The Zacks Consensus Estimate for its 2026 earnings per share has remained stable at $6.58 over the past 30 days, while second-quarter revenues are pegged at $2.17 billion. The company's Transform for the Future program targets approximately $500 million in annual cost savings, with 50-100 basis points of operating margin expansion expected in 2026. However, a potential raw material cost increase from its 3M supply agreement could create a 100-basis-point margin headwind if exercised in 2027. Solventum's first-quarter 2026 results beat estimates, and it projects 7.7% earnings growth for the year.

Impact on stocks 5

Aging Population▲ · 1 stocks
Solventum Corp.
SOLV
▲ PositiveCapitalrelevance

Stable 2026 EPS estimate, cost-saving program, and Q1 beat support earnings growth.

Artificial Intelligence▼ · 1 stocks
3M Company
MMM
▼ NegativeSupplyrelevance

Potential raw material cost increase from 3M supply agreement could create margin headwind for Solventum.

Health Care▲ · 1 stocks
Robotics & Physical AI▲ · 1 stocks
Biotech & Genomic Medicine▲ · 1 stocks
© 2026 MarketDXNews